Literature DB >> 35657584

Size Exclusion Chromatography Strategies and MASH Explorer for Large Proteoform Characterization.

Timothy N Tiambeng1, Zhijie Wu1, Jake A Melby1, Ying Ge2,3,4.   

Abstract

Top-down mass spectrometry (MS)-based analysis of larger proteoforms (>50 kDa) is typically challenging due to an exponential decay in the signal-to-noise ratio with increasing protein molecular weight (MW) and coelution with low-MW proteoforms. Size exclusion chromatography (SEC) fractionates proteins based on their size, separating larger proteoforms from those of smaller size in the proteome. In this protocol, we initially describe the use of SEC to fractionate high-MW proteoforms from low-MW proteoforms. Subsequently, the SEC fractions containing the proteoforms of interest are subjected to reverse-phase liquid chromatography (RPLC) coupled online with high-resolution MS. Finally, proteoforms are characterized using MASH Explorer, a user-friendly software environment for in-depth proteoform characterization.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Data analysis; Proteoforms; Size exclusion chromatography; Top-down proteomics

Mesh:

Substances:

Year:  2022        PMID: 35657584     DOI: 10.1007/978-1-0716-2325-1_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

Review 1.  Intact proteome fractionation strategies compatible with mass spectrometry.

Authors:  Alan A Doucette; John C Tran; Mark J Wall; Shayla Fitzsimmons
Journal:  Expert Rev Proteomics       Date:  2011-12       Impact factor: 3.940

2.  Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry.

Authors:  Shawna Mae Hengel; Russell Sanderson; John Valliere-Douglass; Nicole Nicholas; Chris Leiske; Stephen C Alley
Journal:  Anal Chem       Date:  2014-03-14       Impact factor: 6.986

3.  On the scalability and requirements of whole protein mass spectrometry.

Authors:  Philip D Compton; Leonid Zamdborg; Paul M Thomas; Neil L Kelleher
Journal:  Anal Chem       Date:  2011-07-29       Impact factor: 6.986

4.  Ultrahigh pressure fast size exclusion chromatography for top-down proteomics.

Authors:  Xin Chen; Ying Ge
Journal:  Proteomics       Date:  2013-07-30       Impact factor: 3.984

5.  Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms.

Authors:  Leah V Schaffer; Trisha Tucholski; Michael R Shortreed; Ying Ge; Lloyd M Smith
Journal:  Anal Chem       Date:  2019-08-14       Impact factor: 6.986

6.  A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Authors:  Trisha Tucholski; Samantha J Knott; Bifan Chen; Paige Pistono; Ziqing Lin; Ying Ge
Journal:  Anal Chem       Date:  2019-02-25       Impact factor: 6.986

Review 7.  Top-Down Proteomics: Ready for Prime Time?

Authors:  Bifan Chen; Kyle A Brown; Ziqing Lin; Ying Ge
Journal:  Anal Chem       Date:  2017-12-15       Impact factor: 6.986

8.  Top-down proteomics: challenges, innovations, and applications in basic and clinical research.

Authors:  Kyle A Brown; Jake A Melby; David S Roberts; Ying Ge
Journal:  Expert Rev Proteomics       Date:  2020-12-17       Impact factor: 3.940

9.  Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates.

Authors:  Paula Hong; Stephan Koza; Edouard S P Bouvier
Journal:  J Liq Chromatogr Relat Technol       Date:  2012-11-30       Impact factor: 1.467

10.  Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum.

Authors:  Timothy N Tiambeng; David S Roberts; Kyle A Brown; Yanlong Zhu; Bifan Chen; Zhijie Wu; Stanford D Mitchell; Tania M Guardado-Alvarez; Song Jin; Ying Ge
Journal:  Nat Commun       Date:  2020-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.